---
title: "INNOSTAR (688710): Won the procurement project of Tongji University, with a bid amount of 1.82 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287610957.md"
description: "INNOSTAR (688710) won the bid for a procurement project at Tongji University, amounting to 1.82 million yuan. The operating revenue for 2025 is expected to be 811 million yuan, with a net profit of -31 million yuan. In the first quarter of 2026, the operating revenue is projected to be 210 million yuan, with a net profit of 12 million yuan"
datetime: "2026-05-26T09:29:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287610957.md)
  - [en](https://longbridge.com/en/news/287610957.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287610957.md)
generator: "portal-rs"
---

# INNOSTAR (688710): Won the procurement project of Tongji University, with a bid amount of 1.82 million yuan

According to Tongbi Finance, data from Qichacha shows that based on the "Procurement Announcement for the Preclinical Toxicology Research and Efficacy Research of Class I New Drug Thymus Vaccine by Tongji University," Shanghai INNOSTAR Biotechnology Co., Ltd. announced on May 26, 2026, that it won the bid for the procurement project of Tongji University, with a bid amount of 1.82 million yuan.

Related listed company: INNOSTAR (688710.SH)

*Tongbi Finance Tip:*

*INNOSTAR (688710.SH) had an operating income of 811 million yuan in 2025, with an operating income growth rate of -28.94%. The net profit attributable to the parent company was -31 million yuan, with a net profit growth rate of -120.65%, and the return on net assets was -1.29%.*

*In the first quarter of 2026, the company's operating income was 210 million yuan, with an operating income growth rate of 0.43%. The net profit attributable to the parent company was 12 million yuan, with a net profit growth rate of 121.23%.*

*Currently, the company belongs to the healthcare industry, with the main product type being professional consulting services.*

### Related Stocks

- [688710.CN](https://longbridge.com/en/quote/688710.CN.md)

## Related News & Research

- [Impiricus Launches QPharma® Integration to Power Real-Time Compliant HCP Sampling](https://longbridge.com/en/news/296957896.md)
- [North Sea Crude-WTI weakens on lower offer](https://longbridge.com/en/news/296813963.md)
- [Is Wall Street Bullish or Bearish on Alexandria Real Estate Stock?](https://longbridge.com/en/news/296925778.md)
- [Sugar Prices Consolidate Below Last Week’s Significant Highs](https://longbridge.com/en/news/296819776.md)
- [The Treasury's bond-market intervention isn't working. So what comes next?](https://longbridge.com/en/news/296702361.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**